Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Osborne, K.
Right arrow Articles by Miller, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osborne, K.
Right arrow Articles by Miller, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2000;29:362-368
© International Epidemiological Association 2000

Ten years of serological surveillance in England and Wales: methods, results, implications and action

Kate Osbornea, Nigel Gaya, Louise Heskethb, Peter Morgan-Capnerc and Elizabeth Millera

a PHLS Sero-Epidemiology Unit, Immunisation Division, Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, UK.
b PHLS Sero-Epidemiology Unit, Preston Public Health Laboratory, Royal Preston Hospital, PO Box 202, Sharoe Green Lane, Fulwood, Preston, Lancashire PR2 9HG, UK.
c PHLS Sero-Epidemiology Unit, Public Health Laboratory Service North West, Directorate Office, Vicarage Lane, Fulwood, Preston, Lancashire PR2 8DW, UK.

Background The first age-stratified serological survey of antibody to measles, mumps and rubella in the UK was conducted in 1986/87 prior to the introduction of MMR vaccine into the immunization programme. Serum collection and testing have continued annually, allowing trends over time to be monitored. These sera have also been available for ad hoc surveys of other infections.

Methods Residual sera are collected in participating laboratories and sent to a central store where they are irrevocably unlinked from identifying data. A unique identity number is assigned to each serum and details of age and sex are collated on a database. The sera are accessed for testing as required.

Results The results of recurring and other surveys performed over the last ten years are presented. These demonstrate that opportunistic serum samples are an ideal resource for serological surveillance programmes.

Conclusions The serological surveillance programme has provided past exposure profiles for many infections. These data have resulted in a number of national policy changes and have been instrumental in shaping the UK vaccination programme.

Keywords Serological surveillance, immunization, vaccine preventable diseases, mathematical modelling, MMR

Accepted 27 August 1999


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CVIHome page
C. L. Trotter, R. Borrow, J. Findlow, A. Holland, S. Frankland, N. J. Andrews, and E. Miller
Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination Era
Clin. Vaccine Immunol., November 1, 2008; 15(11): 1694 - 1698.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
P. Balmer, R. Borrow, J. Findlow, R. Warrington, S. Frankland, P. Waight, R. George, N. Andrews, and E. Miller
Age-Stratified Prevalences of Pneumococcal-Serotype-Specific Immunoglobulin G in England and Their Relationship to the Serotype-Specific Incidence of Invasive Pneumococcal Disease Prior to the Introduction of the Pneumococcal 7-Valent Conjugate Vaccine
Clin. Vaccine Immunol., November 1, 2007; 14(11): 1442 - 1450.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
C. Trotter, J. Findlow, P. Balmer, A. Holland, R. Barchha, N. Hamer, N. Andrews, E. Miller, and R. Borrow
Seroprevalence of Bactericidal and Anti-Outer Membrane Vesicle Antibodies to Neisseria meningitidis Group B in England
Clin. Vaccine Immunol., July 1, 2007; 14(7): 863 - 868.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
P. Bellaby
Has the UK government lost the battle over MMR?
BMJ, March 12, 2005; 330(7491): 552 - 553.
[Full Text] [PDF]

Home page
 BMJHome page
J. McVernon, C. L Trotter, M. P E Slack, and M. E Ramsay
Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study
BMJ, September 18, 2004; 329(7467): 655 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. C. Morris-Cunnington, W. J. Edmunds, E. Miller, and D. W. G. Brown
A Population-based Seroprevalence Study of Hepatitis A Virus Using Oral Fluid in England and Wales
Am. J. Epidemiol., April 15, 2004; 159(8): 786 - 794.
[Abstract] [Full Text] [PDF]

Home page
 Epidemiol RevHome page
A. J. Vyse, N. J. Gay, J. M. White, M. E. Ramsay, D. W. G. Brown, B. J. Cohen, L. M. Hesketh, P. Morgan-Capner, and E. Miller
Evolution of Surveillance of Measles, Mumps, and Rubella in England and Wales: Providing the Platform for Evidence-based Vaccination Policy
Epidemiol. Rev., December 1, 2002; 24(2): 125 - 136.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.